Journal of the National Comprehensive Cancer Network

18 papers11 directions
The Journal of the National Comprehensive Cancer Network (JNCCN) is a clinical publication that has featured machine learning and artificial intelligence research within the context of oncology since 2014. While its primary focus is on cancer care and clinical guidelines, the journal serves as a venue for applying computational methods to improve patient outcomes and healthcare delivery. Research in this venue often bridges the gap between technical innovation and clinical practice, focusing on the practical implementation of digital tools in oncology settings. Machine learning and AI research at this venue typically addresses clinical decision support, patient monitoring, and health services research. Examples of published work include the development of machine learning-based early warning systems to predict acute care utilization during systemic therapy and the use of artificial intelligence in broader oncological applications. The journal also explores digital interventions, such as those designed to address sexual health in transplant survivors, and the use of data-driven approaches to analyze geographic accessibility and screening completion. Prolific contributors to the journal include researchers such as Areej El-Jawahri, Jennifer S. Temel, and Joseph K. Salama. The venue's role in the machine learning community is centered on the validation and clinical integration of algorithms rather than purely theoretical developments. By publishing studies on inherited mutations, skeletal muscle associations with clinical outcomes, and systematic reviews of immunotherapy complications, the journal provides a platform for evaluating how computational models perform within complex medical environments.

Papers by Year

2025 2
2024 4
2023 1
2021 3
2020 3
2019 2
2018 1
2017 1
2014 1

Top Research Directions

Research directions most represented by papers from this venue.

Preoperative Staging Inaccuracy and Stage Migration 1
Patient Reported Outcome Measures for Evaluating Treatment Success 1
False Discovery Rate Control for High Dimensional Data 1
The Aging Prevalence Paradox in Global Health Burden 1
Mechanisms of the Clinical Implementation Gap 1
Covariate Balancing via Propensity Score Matching 1
Proportional Hazards Modeling for Survival Analysis 1
Real-World Evidence from Population-Based Cancer Registries 1
Objective Sensing to Mitigate Self-Reporting Bias 1
Confounding by Indication in Observational Health Studies 1
Systemic Biases and Causal Limitations in Retrospective Studies 1

Top Authors

AuthorPapers
Alexander Baras1
Barbara D. Lam1
Hongfeng Ge1
Jeremy Yuen-Chun Teoh1
Juan Du1
Luqun Wang1
Xiaoling Guo1
Yongqian Jia1

Impactful Papers

Papers from this venue that shaped research clusters.

Influential

Papers

TitleYear
A Digital Intervention to Address Sexual Health in Hematopoietic Stem Cell Transplant Survivors2025
CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma2025
Artificial Intelligence in Oncology2024
CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature2024
Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population2024
Local Recurrence and Survival in Patients With Melanoma >2 mm in Thickness at Difficult Sites Treated With 1-cm Versus 2-cm Margins2024
Machine Learning–Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for Cancer2023
Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer2021
Inherited Mutations in Chinese Men With Prostate Cancer2021
Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors2021
CLO20-069: Evaluation and analysis of postoperative complications after primary cytoreduction for 47 cases of advanced epithelial ovarian cancer at stage IIIc and IV RUNNING HEAD (maximum 40 character2020
Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes2020
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis2020
Authors’ Reply2019
Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry2019
Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling2018
Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology2017
Impact of a Clinical Trial Initiative on Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic2014